GENX:TSXV, Genix Pharmaceuticals Corporation

Why GENX stock fell on November 9

Genix Pharmaceuticals Corporation fell 25.0% on Monday, November 9, 2026, on 1,565 shares. No headline about GENX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

GENX stock overview

Genix Pharmaceuticals Corporation (GENX:TSXV) closed at $0.015 on November 4, 2026, unchanged on the day. It is trading at its 52-week low of $0.015. Over the past year, it lost 50.0%. Genix Pharmaceuticals Corporation is part of the Health Care sector.

Key figures

Price
$0.015
Day change
0.00%
Volume
1,565
Average volume
7,120
Market cap
918K+
52-week range
$0.015 – $0.030
50-day average
$0.020
200-day average
$0.020

Price action over the past year

In 252 trading sessions since November 12, 2025, GENX closed higher on 2 days (1%). Its best day was December 23, 2025 (+50.00%) and its worst was December 19, 2025 (-33.33%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

About Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corp is a Canadian life sciences company engaged in the research, development, manufacturing and marketing of high growth, high margin, novel and proprietary, evidence-based, pharmaceuticals, over-the-counter products, nutraceuticals and healthcare products, as well as generic medicines.

Similar stocks

Find more stocks like GENX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.